Trials / Unknown
UnknownNCT06288334
Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Peking University Third Hospital · Academic / Other
- Sex
- All
- Age
- 6 Months – 16 Years
- Healthy volunteers
- Not accepted
Summary
To obtain the pharmacokinetics of cetirizine in Chinese children with allergic disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 1-3 Cetirizine Pharmacokinetic samples | Limited sampling strategy was used in this study. For each child, only 1\~3 blood samples were collected before and after cetirizine administration. |
Timeline
- Start date
- 2020-08-06
- Primary completion
- 2024-03-31
- Completion
- 2024-05-31
- First posted
- 2024-03-01
- Last updated
- 2024-03-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06288334. Inclusion in this directory is not an endorsement.